Daniel Almquist
Overview
Explore the profile of Daniel Almquist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agarwal M, Liu A, Almquist D, Langlais B, Leventakos K, Yu N, et al.
Cancer
. 2023 Aug;
129(22):3546-3553.
PMID: 37548029
Background: Immune checkpoint inhibitor combined with platinum-etoposide is the standard first-line therapy for patients with extensive-stage small cell lung cancer (ES-SCLC). The phase 3 clinical trials that led to the...
2.
Agarwal M, Liu A, Langlais B, Leventakos K, Yu N, Almquist D, et al.
Clin Lung Cancer
. 2023 Jun;
24(7):591-597.
PMID: 37365076
Background: Studies demonstrated that chemoimmunotherapy prolongs progression-free survival (PFS) and overall survival (OS) in patients with extensive-stage small-cell lung cancer (ES-SCLC) and an Eastern Cooperative Oncology Group performance status (ECOG...
3.
Almquist D, Umakanthan J, Ganti A
JCO Precis Oncol
. 2022 Feb;
2:1-5.
PMID: 35135125
No abstract available.
4.
Almquist D, Ernani V
JCO Oncol Pract
. 2020 Nov;
17(1):7-14.
PMID: 33211628
Over the past decade, significant advances have been achieved in the diagnostic testing, treatment, and prognosis of advanced non-small-cell lung cancer (NSCLC). One of the most significant developments was the...
5.
Al-Toubah T, Strosberg J, Halfdanarson T, Oleinikov K, Gross D, Haider M, et al.
Chest
. 2020 Feb;
158(1):401-405.
PMID: 32059961
Background: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare lung disease associated with proliferation of neuroendocrine cells in the lung and multifocal neuroendocrine tumorlets/tumors. Although usually considered an...
6.
Almquist D, Khanal N, Smith L, Ganti A
Anticancer Res
. 2018 May;
38(5):2903-2907.
PMID: 29715115
Background: Preoperative pulmonary function tests (PFTs) predict operative morbidity and mortality after resection in lung cancer. However, the impact of preoperative PFTs on overall outcomes in surgically-resected stage I and...
7.
Almquist D, Mosalpuria K, Ganti A
J Oncol Pract
. 2016 Feb;
12(2):111-7.
PMID: 26869647
Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been the mainstay of...